Mid-Atlantic Allergy Conference 2024
To register for this event go to: https://maacallergy.org/
The Mid-Atlantic Allergy Conference will be hosting its annual meeting on October 5, 2024 in Bethany Beach, Delaware. The program will include CME lectures on topics relevant to the practicing allergists at a relaxing setting. Our goal is to provide education while promoting camaraderie and support for the private practice allergists.
Target Audience
- A/I Physicians
- Fellows-in-Training
- Residents
- Physician Assistants
- Nurse Practitioners
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify cutaneous lesions that may have features of allergic rashes
- Explain new concepts in managing food allergies including food ladders and OIT dosing
- Discuss new treatments to best manage asthma
- Describe mast cell dysregulation and it impact on disease
- Evaluate and manage patients with PIDD/inborn errors of immunity
Additional Information
Attachment | Size |
---|---|
2024 MAAC Agenda.pdf | 50.45 KB |
The information disclosed by the speakers, planning committee, and reviewers was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Planning Committee
Lisa Barisciano, MD
Pediatric and Adult Asthma, Allergy & Immunology
Relevant relationships: Optinose (Speaker)
Sally Joo Bailey, MD FAAAAI
Allergy Associates of Northern VA
Relevant relationships: None
Tina C. Zecca, DO
Allergy Asthma Associates of Monmouth County
Relevant relationships: None
Faculty
Antoine Azar, MD FAAAAI
The Johns Hopkins University School of Medicine, Allergy & Clinical Immunology
Relevant relationships: ADMA, ArgenX, Takeda (consultant); CSL Behring, Octapharma (advisory board); X4 pharmaceuticals (research grant)
Stephen D. Hess, MD, PhD
Center City Dermatology
Relevant relationships: None
Rohit Katial, MD FAAAAI
National Jewish Health
Relevant relationships: GSK (advisory board); Sanofi Regeneron (speaker); AstraZeneca (other)
Anne L. Maitland, MD PhD
Metrodora Institute
Relevant relationships: None
Marcus S. Shaker, MD MS FAAAAI
Dartmouth-Hitchcock Medical Center
Relevant relationships: None
CME Reviewer
Kevin W. Parks, MD FAAAAI
AAC/CRI of Southern Oregon, P. C.
Relevant relationships: None
Thomas Miller MD FAAAAI
Allergy, Asthma & Pulmonary Associates
Relevant relationships: None
Scott H. Sicherer, MD FAAAAI
Mt. Sinai School of Medicine
Relevant relationships: None
Anne F. Russell, MS BSN RN AE-C
Spring Arbor University
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Mid-Atlantic Allergy Conference. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on September 30, 2025. Requests to claim credit on or after October 1, 2025 will be subject to an administrative fee.
Medium and Method of Physician Participation for a Live Activity
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME Info Page online or in person
- Attend the meeting
- Navigate to the AAAAI webpage for credit claiming
- Enter the attendance code received at the live activity
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
Questions
Activity-related questions should be directed to cme@aaaai.org.
Available Credit
- 5.00 AttendanceAttendance credit.
- 5.00 CMECME credit.